Does CLOBETASOL Cause Therapeutic product ineffective? 59 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Therapeutic product ineffective have been filed in association with CLOBETASOL (CLOBETASOL PROPIONATE). This represents 0.8% of all adverse event reports for CLOBETASOL.
59
Reports of Therapeutic product ineffective with CLOBETASOL
0.8%
of all CLOBETASOL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapeutic product ineffective From CLOBETASOL?
Of the 59 reports, 2 (3.4%) required hospitalization, and 1 (1.7%) were considered life-threatening.
Is Therapeutic product ineffective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOBETASOL. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does CLOBETASOL Cause?
Drug ineffective (3,217)
Psoriasis (1,317)
Product use in unapproved indication (706)
Pruritus (697)
Therapeutic product effect incomplete (643)
Skin exfoliation (550)
Off label use (540)
Treatment failure (535)
Erythema (464)
Arthralgia (417)
What Other Drugs Cause Therapeutic product ineffective?
ALBUTEROL (379)
METHYLPHENIDATE (135)
METHOTREXATE (133)
ESTRADIOL\NORETHINDRONE (132)
ESTRADIOL (124)
SECUKINUMAB (111)
PREDNISONE (59)
TRIAMCINOLONE (51)
BUPRENORPHINE\NALOXONE (44)
ADALIMUMAB (43)
Which CLOBETASOL Alternatives Have Lower Therapeutic product ineffective Risk?
CLOBETASOL vs CLOBETASONE
CLOBETASOL vs CLODRONATE
CLOBETASOL vs CLOFARABINE
CLOBETASOL vs CLOFAZIMINE
CLOBETASOL vs CLOMETHIAZOLE